Bioequivalence and Bioavailability Forum 12:07 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

BCS II waiver approach [Dissolution / BCS / IVIVC]

posted by yuvaneshwari - India, 2019-01-23 06:09  - Posting: # 19801
Views: 366

Dear All,

Drug compound is BCS-II [dosage form is solution filled in capsule], and objective is to formulate with Q1 & Q2 sameness to that of Reference. Since API is in solution state filled in capsule, its solubility/bioavailability is improved tremendously.

In the above scenario, can we consider for BCS based waiver approach ?

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,187 posts in 4,084 threads, 1,308 registered users;
online 12 (0 registered, 12 guests [including 9 identified bots]).

In these days, a man who says a thing cannot be done
is quite apt to be interrupted by some idiot doing it.    Elbert Green Hubbard

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed